Ar­row­head re­veals small batch of open-la­bel da­ta for 'non-core' kid­ney drug

Ar­row­head Phar­ma­ceu­ti­cals on Mon­day shared new open-la­bel da­ta in about a dozen pa­tients for a pro­gram de­signed to im­prove cer­tain kid­ney dis­ease out­comes by tar­get­ing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER